Preclinical Study using Malat1 Small Interfering RNA or Androgen Receptor Splicing Variant 7 Degradation Enhancer ASC-J9® to Suppress Enzalutamide-resistant Prostate Cancer Progression

Ronghao Wang, Yin Sun, Lei Li, Yuanjie Niu, Wanying Lin, Changyi Lin, Emmanuel S. Antonarakis, Jun Luo, Shuyuan Yeh, Chawnshang Chang

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Preclinical Study using Malat1 Small Interfering RNA or Androgen Receptor Splicing Variant 7 Degradation Enhancer ASC-J9<sup>®</sup> to Suppress Enzalutamide-resistant Prostate Cancer Progression'. Together they form a unique fingerprint.

Medicine & Life Sciences